Skip to main content

Table 1 Characteristics of study populations

From: Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema

 

Baseline values

After 1 year values

P*

Age (Avg [SD])†, years

59.3 (9.9)

  

Male: Female

12:23

  

Hypertension

12 (34.3%)

  

CKD

2 (5.6%)

  

Dyslipidemia

7 (19.4%)

  

HbA1c (Avg [SD])

7.96 (1.61) %

7.56 (1.22) %

0.105

BUN (Avg [SD])

18.1 (5.2) mg/dl

20.4 (7.6) mg/dl

0.052

Cr (Avg [SD])

1.02 (1.19) mg/dl

1.19 (0.99) mg/dl

0.073

TG (Avg [SD])

171.0 (77.2) mg/dl

148.9 (82.6) mg/dl

0.122

Total cholesterol (Avg [SD])

183.8 (53.5) mg/dl

170.4 (39.0) mg/dl

0.222

HDL (Avg [SD])

50.0 (15.0) mg/dl

50.7 (12.0) mg/dl

0.859

LDL (Avg [SD])

120.4 (52.0) mg/dl

100.8 (37.1) mg/dl

0.048‡

diffuse: focal edema

16 (45%):19 (55%)

  

Presence of SRF

11 (31%)

  

Microaneurysm count (Avg [SD])

15.3 (13.3)

13.1 (10.5)

0.032‡

  1. CKD chronic kidney disease, Presence of SRF presence of macular subretinal fluid, BUN blood urea nitrogen, Cr creatinine, TG triglyceride, HDL high density lipoprotein, LDL low density lipoprotein
  2. *paired t-test; †Avg [SD]: average [standard deviation]; ‡P < 0.05